Hormone News and Research

RSS

A hormone is a chemical released by one or more cells that affects cells in other parts of the organism. Only a small amount of hormone is required to alter cell metabolism. It is essentially a chemical messenger that transports a signal from one cell to another.

New findings help explain why toxoplasmosis causes serious disease

Providing clues into why the severity of a common parasitic infection can vary greatly from person to person, a new Johns Hopkins study shows that each one of three strains of the cat-borne parasite Toxoplasma gondii sets off a unique reaction in the nerve cells it invades.

15 Mar 2011

Oxford Biomedica’s TroVax(R) TRIST Phase III study results to be published in Cancer Immunology, Immunotherapy

Oxford BioMedica plc, a leading gene therapy company, today announces that further analyses of the TroVax Renal Immunotherapy Survival Trial, a randomised, double-blind, placebo-controlled Phase III study, have been accepted for publication in Cancer Immunology, Immunotherapy, the official journal of the Association for Cancer Immunotherapy.

15 Mar 2011

LRC professors develop daylighting design guide for school students

The body's internal clock is responsible for regulating the timing of our sleep and other daily biological cycles, called circadian rhythms. During school months, however, teenagers miss out on essential morning light needed to stimulate the 24-hour biological clock.

15 Mar 2011

How male puberty begins

Scientists from Monash University have uncovered a new understanding of how male puberty begins.

14 Mar 2011

KAI initiates enrollment in KAI-4169 Phase 2 study for secondary hyperparathyroidism

KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced enrollment of the first patients in a Phase 2 study of KAI-4169, a novel pharmaceutical agent being tested for the treatment of secondary hyperparathyroidism (SHPT), which is a frequent and serious complication of end-stage renal disease (ESRD).

14 Mar 2011

Research links giftedness to prenatal exposure of testosterone

A longstanding debate as to whether genius is a byproduct of good genes or good environment has an upstart challenger that may take the discussion in an entirely new direction. University of Alberta researcher Marty Mrazik says being bright may be due to an excess level of a natural hormone.

14 Mar 2011

Acupuncture for menopausal hot flashes: Study

According to a new study, women who suffer from hot flashes and other uncomfortable symptoms of menopause may be able to find relief through acupuncture. These symptoms plague menopausal women and usual therapy for it is hormone replacement therapy but that has its own problems including an increased risk of coronary heart disease, stroke and breast cancer.

12 Mar 2011

Testosterone associated with dominant behavior and competitive success in attracting women

Theories have long proposed that testosterone influences competition among males trying to attract females. Findings from a recent study at Wayne State University give a clearer understanding of the links between testosterone and human mating behavior, and how testosterone is associated with dominance and competitive success when men battle for the attention of an attractive woman.

11 Mar 2011

New technique may find 'hidden' receptors in nerve cells

Scientists at The Scripps Research Institute and University of Pennsylvania have found a way to uncover potential drug targets that have so far remained hidden from researchers' view.

11 Mar 2011

Majority of men on ADT after prostatectomy gain weight during first year of therapy

Seventy per cent of men who received androgen-deprivation therapy (ADT) after surgery to remove their prostate gland gained significant weight in the first year, putting on an average of 4.2kg, according to a paper in the March issue of the urology journal BJUI.

11 Mar 2011

Sanofi-aventis, Regeneron announce results of VEGF Trap Phase III trial in second-line NSCLC

Sanofi-aventis and Regeneron Pharmaceuticals, Inc. announced results from the Phase III VITAL trial evaluating the investigational agent aflibercept (VEGF Trap) for the second-line treatment of non-small cell lung cancer (NSCLC).

11 Mar 2011

New discovery: GPCR family of proteins can recognize and respond to wide array of signals

Scientists from The Scripps Research Institute have determined a new structure from a medically important superfamily of proteins. The structure should help instruct the design of a new kind of therapeutics for conditions ranging from Parkinson's disease to inflammation.

11 Mar 2011

SAP may serve as effective nanomaterial to prevent prostate cancer spread

When prostate cancer stem cells were enclosed in self-assembling nanomaterials made of peptides, the SAP stopped cancer stem cell colony formation and also stopped the division of cancer cells in laboratory cultures.

11 Mar 2011

Positive results from exenatide phase 2 study in patients with type 2 diabetes

Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a phase 2 study evaluating the effects of a once-monthly injectable suspension formulation of exenatide on glycemic control in patients with type 2 diabetes.

10 Mar 2011

Novel sortase-based techniques allow modification of a large variety of different proteins

Whitehead Institute scientists have created a method that site-specifically modifies proteins to exert control over their properties when administered therapeutically. The technique should be useful to increase potency, slow metabolism, and improve thermal stability of therapeutically useful proteins, such as interferon alpha 2 (IFN-alpha 2), which is used to treat variety of diseases, including leukemia, melanoma, and chronic hepatitis C.

10 Mar 2011

Researchers pinpoint a protein responsible for fat storage in the body

Scientists have shed light on why some people are apple-shaped and others are pear-shaped.

10 Mar 2011

Lowering cholesterol could help fight infections

British researchers have found that lowering cholesterol levels could help the body’s immune system fight infections. The team at the University of Edinburgh conducted the experiments on mice and found a direct link between the workings of the immune system and cholesterol levels.

9 Mar 2011

Merck to present VICTRELIS phase III study data against HCV at EASL annual meeting

Merck, known as MSD outside of the United States and Canada, announced that several new data analyses from Phase III studies of VICTRELIS, its investigational oral hepatitis C protease inhibitor, will be presented at The International Liver CongressTM / 46th European Association for the Study of the Liver annual meeting.

9 Mar 2011

Autologous fat stem cell therapies for eternal life

Whereas formerly often only the symptoms of age were treated in cosmetic medicine, autologous stem cell-assisted regenerative therapies take a more comprehensive approach: the abundant stem cells in fat tissue are extracted and introduced in the body. The autologous stem cells then exert their regenerative power in the body where needed. Organs and tissues are regenerated and rejuvenated; even degenerative and chronic diseases are treatable.

9 Mar 2011

URMC research confirms possible use of mifepristone for painful fibroids

Research continues to show that the controversial abortion drug mifepristone might have another use, as a therapeutic option besides hysterectomy for women who suffer from severe symptoms associated with uterine fibroids.

8 Mar 2011

Hormone News and Research

Further Reading

New findings help explain why toxoplasmosis causes serious disease

Oxford Biomedica’s TroVax(R) TRIST Phase III study results to be published in Cancer Immunology, Immunotherapy

LRC professors develop daylighting design guide for school students

How male puberty begins

KAI initiates enrollment in KAI-4169 Phase 2 study for secondary hyperparathyroidism

Research links giftedness to prenatal exposure of testosterone

Acupuncture for menopausal hot flashes: Study

Testosterone associated with dominant behavior and competitive success in attracting women

New technique may find 'hidden' receptors in nerve cells

Majority of men on ADT after prostatectomy gain weight during first year of therapy

Sanofi-aventis, Regeneron announce results of VEGF Trap Phase III trial in second-line NSCLC

New discovery: GPCR family of proteins can recognize and respond to wide array of signals

SAP may serve as effective nanomaterial to prevent prostate cancer spread

Positive results from exenatide phase 2 study in patients with type 2 diabetes

Novel sortase-based techniques allow modification of a large variety of different proteins

Researchers pinpoint a protein responsible for fat storage in the body

Lowering cholesterol could help fight infections

Merck to present VICTRELIS phase III study data against HCV at EASL annual meeting

Autologous fat stem cell therapies for eternal life

URMC research confirms possible use of mifepristone for painful fibroids

Viva Saliva Book: The ultimate guide to saliva Book preview Download eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News